Regulatory role for cytosolic nucleic acid sensors in bone

细胞质核酸传感器在骨中的调节作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Innate immune sensors detect nucleic acid from viral and bacterial infections to clear infection, and also detect endogenous nucleic acid from stressed or dying cells. Toll-like receptors have long been known to detect nucleic acid, while nucleic acid sensors within the cytosol have only recently been discovered. Activation of cytosolic DNA sensor pathways has been associated with autoimmune disease in which DNA from apoptotic cells accumulates. In addition, endogenous sources of DNA within cells can activate these pathways, including oxidized, "damaged" DNA that accrues with aging and can escape degradation, as well as DNA derived from replication of endogenous retroelements within the human genome. Despite the importance of these pathways, little is known about their role in cell types other than macrophages and dendritic cells. Data from our laboratory demonstrate a potentially important role for cytosolic DNA sensor pathways in bone that may provide insight into the bone loss occurring in aging and in certain autoimmune diseases. Several cytosolic DNA sensors signal through an ER-associated protein, stimulator of interferon genes (STING), including interferon-inducible protein 16 (IFI16/p204) and cyclic GMP-AMP synthase (cGAS), resulting in the production of type I interferons and proinflammatory cytokines. The cytosolic DNA sensor AIM2 does not signal through STING, but instead coordinates the assembly of an inflammasome complex, resulting in IL-1b production. We demonstrate that cytosolic DNA sensors are expressed in both osteoclast (OC) and osteoblast (OB)-lineage cells and that STING deficient mice are osteopenic, whereas AIM2 deficient mice accrue bone in long bones. Furthermore, STING and AIM2 differentially modulate the bone phenotype in a mouse model of arthritis in which cytoplasmic DNA accumulates due to deficiency in DNaseII. We hypothesize that the STING and AIM2 pathways regulate OC and/or OB differentiation/function. Aim 1 will determine the cell-intrinsic role of the STING and AIM2 pathways in OC differentiation and/or function. Part A will determine the role of STING in osteoclastogenesis through regulation of the inhibitor of OC function, A20, or through production of cytokines. Part B will determine inflammasome-dependent or independent roles of AIM2 in OC differentiation/function. We will explore the role of these pathways in OBs as an alternative approach. Finally, in Aim 2 we will determine the impact of the STING and AIM2 pathways on expression of macrophage-derived cytokines/factors that regulate bone remodeling. This proposal explores the entirely novel hypothesis that cytosolic DNA sensors and their ligands regulate bone remodeling and may be relevant to pathologic bone remodeling in aging and autoimmunity.
描述(由申请人提供):先天免疫传感器检测来自病毒和细菌感染的核酸以清除感染,并且还检测来自应激或垂死细胞的内源性核酸。Toll样受体早已被认为可以检测核酸,而细胞质内的核酸传感器只是最近才被发现。细胞溶质DNA传感器途径的激活与来自凋亡细胞的DNA积累的自身免疫性疾病相关。此外,细胞内DNA的内源性来源可以激活这些途径,包括随着衰老而积累并可以逃避降解的氧化的“受损”DNA,以及源自人类基因组内内源性逆转录元件复制的DNA。尽管这些途径的重要性,很少有人知道他们在细胞类型以外的巨噬细胞和树突状细胞的作用。来自我们实验室的数据表明,细胞溶质DNA传感器通路在骨中可能发挥重要作用,这可能有助于了解衰老和某些自身免疫性疾病中发生的骨丢失。几种胞质DNA传感器通过ER相关蛋白、干扰素基因刺激物(STING)(包括干扰素诱导蛋白16(IFI 16/p204)和环GMP-AMP合酶(cGAS))发出信号,导致I型干扰素和促炎细胞因子的产生。细胞溶质DNA传感器AIM 2不通过STING发出信号,而是协调炎性小体复合物的组装,导致IL-1b的产生。我们证明,细胞溶质DNA传感器在破骨细胞(OC)和成骨细胞(OB)谱系细胞中表达,STING缺陷型小鼠骨质减少,而AIM 2缺陷型小鼠在长骨中积累骨。此外,STING和AIM 2差异调节关节炎小鼠模型中的骨表型,其中细胞质DNA由于DNaseII缺乏而积累。我们假设STING和AIM 2途径调节OC和/或OB分化/功能。目的1将确定STING和AIM 2途径在OC分化和/或功能中的细胞内在作用。A部分将确定STING通过调节OC功能抑制剂A20或通过产生细胞因子在破骨细胞生成中的作用。部分B将确定AIM 2在OC分化/功能中的炎性小体依赖性或独立性作用。我们将探讨这些途径在OBs中的作用作为一种替代方法。最后,在目标2中,我们将确定STING和AIM 2通路对调节骨重建的巨噬细胞源性细胞因子/因子表达的影响。该提案探索了一个全新的假设,即细胞溶质DNA传感器及其配体调节骨重建,并可能与衰老和自身免疫中的病理性骨重建有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ellen M Gravallese其他文献

Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study
嵌合抗原受体(CAR)T细胞疗法用于存在自身免疫性或炎症性疾病患者癌症治疗的安全性:一项回顾性对比队列研究
  • DOI:
    10.1016/s2665-9913(24)00402-8
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    16.400
  • 作者:
    Kathleen M M Vanni;Kaitlin R McCarter;Xiaosong Wang;Caitlyn Duffy;Jamie P Dela Cruz;Holly Wobma;Sarah Nikiforow;Elena M Massarotti;Karen H Costenbader;Jessica S Little;Ellen M Gravallese;Gregory C McDermott;Caron A Jacobson;Jeffrey A Sparks
  • 通讯作者:
    Jeffrey A Sparks
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023
风湿病领域未满足的需求:2023年靶向治疗进展会议报告
  • DOI:
    10.1136/ard-2023-224916
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
    20.600
  • 作者:
    Kevin L Winthrop;Philip Mease;Andreas Kerschbaumer;Reinhard E Voll;Ferdinand C Breedveld;Josef S Smolen;Jacques-Eric Gottenberg;Xenofon Baraliakos;Hans P Kiener;Daniel Aletaha;John D Isaacs;Maya H Buch;Mary K Crow;Jonathan Kay;Leslie Crofford;Ronald F van Vollenhoven;Caroline Ospelt;Stefan Siebert;Margreet Kloppenburg;Iain B McInnes;Ellen M Gravallese
  • 通讯作者:
    Ellen M Gravallese

Ellen M Gravallese的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ellen M Gravallese', 18)}}的其他基金

Novel approaches to promote healing of bone loss in inflammatory arthritis
促进炎症性关节炎骨质流失愈合的新方法
  • 批准号:
    10365023
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
Novel approaches to promote healing of bone loss in inflammatory arthritis
促进炎症性关节炎骨质流失愈合的新方法
  • 批准号:
    10590694
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
Novel approaches to the treatment of bone loss in rheumatoid arthritis
治疗类风湿性关节炎骨质流失的新方法
  • 批准号:
    9572399
  • 财政年份:
    2017
  • 资助金额:
    $ 18.43万
  • 项目类别:
Novel approaches to the treatment of bone loss in rheumatoid arthritis
治疗类风湿性关节炎骨质流失的新方法
  • 批准号:
    9435618
  • 财政年份:
    2017
  • 资助金额:
    $ 18.43万
  • 项目类别:
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis
骨稳态中的 STING 通路和胞质核酸传感器
  • 批准号:
    10190834
  • 财政年份:
    2017
  • 资助金额:
    $ 18.43万
  • 项目类别:
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis
骨稳态中的 STING 通路和胞质核酸传感器
  • 批准号:
    10115967
  • 财政年份:
    2017
  • 资助金额:
    $ 18.43万
  • 项目类别:
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis
骨稳态中的 STING 通路和胞质核酸传感器
  • 批准号:
    9383723
  • 财政年份:
    2017
  • 资助金额:
    $ 18.43万
  • 项目类别:
Regulatory role for cytosolic nucleic acid sensors in bone
细胞质核酸传感器在骨中的调节作用
  • 批准号:
    8808584
  • 财政年份:
    2014
  • 资助金额:
    $ 18.43万
  • 项目类别:
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis
类风湿性关节炎骨侵蚀中成骨细胞功能的抑制
  • 批准号:
    8493996
  • 财政年份:
    2009
  • 资助金额:
    $ 18.43万
  • 项目类别:
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis
类风湿性关节炎骨侵蚀中成骨细胞功能的抑制
  • 批准号:
    8098159
  • 财政年份:
    2009
  • 资助金额:
    $ 18.43万
  • 项目类别:

相似海外基金

Analysis of phagocytic activity of aging macrophage and the accompanying inflammatory response induced by apoptotic cells
衰老巨噬细胞吞噬活性及凋亡细胞诱导的炎症反应分析
  • 批准号:
    18K07183
  • 财政年份:
    2018
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aging and Apoptotic Modulation of Immune Responsiveness
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    7846848
  • 财政年份:
    2008
  • 资助金额:
    $ 18.43万
  • 项目类别:
The effect of aging and smoking on the phagocytosis of apoptotic cells in alveolar macrophages
衰老和吸烟对肺泡巨噬细胞凋亡细胞吞噬作用的影响
  • 批准号:
    20590890
  • 财政年份:
    2008
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aging and Apoptotic Modulation of Immune Responsiveness
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    7673703
  • 财政年份:
    2008
  • 资助金额:
    $ 18.43万
  • 项目类别:
Aging and Apoptotic Modulation of Immune Responsiveness
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    8277273
  • 财政年份:
    2008
  • 资助金额:
    $ 18.43万
  • 项目类别:
Aging and Apoptotic Modulation of Immune Responsiveness
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    8076755
  • 财政年份:
    2008
  • 资助金额:
    $ 18.43万
  • 项目类别:
Aging and Apoptotic Modulation of Immune Responsiveness
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    7532973
  • 财政年份:
    2008
  • 资助金额:
    $ 18.43万
  • 项目类别:
Dendritic cell mediated modulation of tolerance by apoptotic cells in aging
树突状细胞介导衰老过程中凋亡细胞对耐受性的调节
  • 批准号:
    7268013
  • 财政年份:
    2006
  • 资助金额:
    $ 18.43万
  • 项目类别:
AGING AND APOPTOTIC MODULATION OF IMMUNE RESPONSIVENESS
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    6812358
  • 财政年份:
    2004
  • 资助金额:
    $ 18.43万
  • 项目类别:
AGING AND APOPTOTIC MODULATION OF IMMUNE RESPONSIVENESS
免疫反应的衰老和细胞凋亡调节
  • 批准号:
    6938469
  • 财政年份:
    2004
  • 资助金额:
    $ 18.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了